Literature DB >> 7468579

Risk factors for benign breast disease.

L A Brinton, M P Vessey, R Flavel, D Yeates.   

Abstract

The importance of various risk factors for benign breast disorders has been assessed an analysis of data obtained from a multicenter cohort study of contraceptive use among women in the United Kingdom (the Oxford Family Planning Association Contraceptive Study). Cases comprised all women diagnosed as having any type of benign breast lesion; 74 had fibroadenoma, 211 had histologically confirmed chronic cystic disease, 331 had breast lumps not subjected to biopsy and 70 had other disease. Each case was individually matched with another study participant who was free from recognized breast disease. Matching factors were center of recruitment, date of recruitment, age at entry, and continuation in the study. An inverse association was found between use of oral contraceptives and the risk of the first three conditions. Current users of the pill had the lowest risk, particularly when the use was for an extended period. In contrast, past users demonstrated no reduction in risk. The reduction in risk for chronic cystic disease appeared to relate to the amount of progestogen contained in the pill. No significant association was observed between the risk of any of the conditions and either parity or age at first livebirth. Women of low social class and obese women were at low risk, perhaps reflecting diagnostic biases.

Entities:  

Keywords:  Age Factors; Biology; Body Weight; Breast Cancer; Cancer; Cohort Analysis; Demographic Factors; Developed Countries; Diseases; Europe; Fibroadenosis; High Risk Women; Incidence; Mammary Gland Effects; Maternal Age; Neoplasms; Northern Europe; Obesity; Oral Contraceptives; Physiology; Population; Population Characteristics; Puerperal Disorders; Reproduction; Research Methodology; Socioeconomic Status; United Kingdom

Mesh:

Substances:

Year:  1981        PMID: 7468579     DOI: 10.1093/oxfordjournals.aje.a113089

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  15 in total

1.  Trends in the content and use of oral contraceptives in the United States, 1964-88.

Authors:  B B Gerstman; T P Gross; D L Kennedy; R C Bennett; D K Tomita; B V Stadel
Journal:  Am J Public Health       Date:  1991-01       Impact factor: 9.308

2.  Depot medroxyprogesterone and risk of breast cancer.

Authors:  R H Gray
Journal:  BMJ       Date:  1989-10-28

3.  Biomarkers of dietary exposure are associated with lower risk of breast fibroadenomas in Chinese women.

Authors:  S Coosje Dijkstra; Johanna W Lampe; Roberta M Ray; Rose Brown; Chunyuan Wu; Wenjin Li; Chu Chen; Irena B King; Daoli Gao; Yongwei Hu; Jackilen Shannon; Kristiina Wähälä; David B Thomas
Journal:  J Nutr       Date:  2010-05-19       Impact factor: 4.798

4.  Fruit and vegetable intakes are associated with lower risk of breast fibroadenomas in Chinese women.

Authors:  Zakia Coriaty Nelson; Roberta M Ray; Chunyuan Wu; Helge Stalsberg; Peggy Porter; Johanna W Lampe; Jackilen Shannon; Neilann Horner; Wenjin Li; Wenwan Wang; Yongwei Hu; Daoli Gao; David B Thomas
Journal:  J Nutr       Date:  2010-05-19       Impact factor: 4.798

5.  Cigarette smoking and benign breast disease.

Authors:  D Mant; M P Vessey; M A Smith; D Yeates
Journal:  J Epidemiol Community Health       Date:  1986-09       Impact factor: 3.710

Review 6.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

Review 7.  Long-cycle treatment with oral contraceptives.

Authors:  Inka Wiegratz; Herbert Kuhl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Risk factors for histologically confirmed benign breast tumors.

Authors:  M Rautalahti; D Albanes; J Haukka; J Virtamo
Journal:  Eur J Epidemiol       Date:  1994-06       Impact factor: 8.082

9.  Risk factors relevant to cystic breast disease: a case-control study.

Authors:  S W Duffy; M M Roberts; R A Elton
Journal:  J Epidemiol Community Health       Date:  1983-12       Impact factor: 3.710

Review 10.  Management of breast fibroadenomas.

Authors:  R Greenberg; Y Skornick; O Kaplan
Journal:  J Gen Intern Med       Date:  1998-09       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.